In 2023, the mortality rate for prostate malignant neoplasms in Sweden stood at 41.4 units per hundred thousand men, standardised rates. Forecasted data for 2024 indicates a decrease to 40.6, and a year-on-year decline is expected to continue with values reaching 39.8 in 2025, 39.0 in 2026, 38.2 in 2027, and 37.4 in 2028. This shows a consistent downward trend.
Year-on-year variations:
- 2024: -1.9%
- 2025: -2.0%
- 2026: -2.0%
- 2027: -2.1%
- 2028: -2.1%
The Compound Annual Growth Rate (CAGR) over the last five years is estimated at -2.02%, reflecting an average annual decline in mortality rates for prostate malignant neoplasms.
Future trends to watch for include the impact of advancements in early detection and treatment technologies, changes in public health initiatives, and lifestyle factors that could further influence mortality rates for prostate cancer.
